Effects of Vasoactive Drugs on Tumor Blood Flow and Antibody Localization
Author Information
Author(s): M.V. Pimm
Primary Institution: Cancer Research Campaign Laboratories, University of Nottingham
Hypothesis
Can vasoactive drugs like propranolol and pindolol enhance the localization of monoclonal antibodies in human tumor xenografts by altering blood flow?
Conclusion
The study found that beta blockers did not consistently enhance tumor blood flow or improve antibody localization in tumors.
Supporting Evidence
- Propranolol increased tumor blood flow in 3 out of 4 tests but only significantly in 2.
- Pindolol had some effect in 3 out of 3 tests but was statistically significant in only one.
- Neither drug significantly altered the biodistribution of the monoclonal antibody.
Takeaway
The study tested if certain drugs could help cancer-fighting antibodies get to tumors better, but they didn't work as hoped.
Methodology
Nude mice with human tumor xenografts were treated with propranolol and pindolol, and blood flow and antibody localization were measured using radiolabeled antibodies.
Limitations
The effects of the drugs on blood flow were inconsistent and did not significantly enhance antibody localization.
Participant Demographics
Nude mice with human tumor xenografts (Colo-205, HCT8, and 791T).
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website